{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.6059T>C",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "T",
            "alt": "C",
            "position": "6059"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T mutation in the kinase domain"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005315"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell viability assay (apoptosis measurement)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 or SH-SY5Y (not explicitly stated)",
        "Description": "Cells were treated with hydrogen peroxide to induce apoptosis, and proteolysis inhibitors were used to prevent degradation of I2020T mutant LRRK2."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "I2020T mutant LRRK2 showed reduced protective effect against hydrogen peroxide-induced apoptosis compared to wild-type LRRK2 when proteolysis was inhibited."
        },
        {
          "Variant": "Wild-type LRRK2",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Wild-type LRRK2 provided normal protective effect against apoptosis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed (as implied by 'three independent experiments' in the text)."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly stated."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "siRNA knockdown of LRRK2 was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test or ANOVA (implied by comparison of experimental groups)."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression or protective effect within 80-100% of wild-type levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression or protective effect below 50% of wild-type levels.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}